1,4-diazacyclononane | 7234-56-2

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: 1,4-diazacyclononane
• 英文别名: 1,4-Diazonane
• CAS: 7234-56-2
• 化学式: C₇H₁₆N₂
• mdl: MFCD19216520
• 分子量: 128.217
• InChiKey: IMPHZTQBNGCVCV-UHFFFAOYSA-N

物化性质

• 沸点：
  128-133 °C(Press: 24 Torr)
• 密度：
  0.845±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.4
• 重原子数：
  9
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  24.1
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  1,4-diazacyclononane 在 sodium hydroxide 、 lithium aluminium tetrahydride 、 三乙胺 、 sodium iodide 作用下， 以 四氢呋喃 、 乙醚 、 二氯甲烷 、 乙腈 为溶剂， 反应 27.0h， 生成 1--4-butane
  参考文献：
  名称：

  On the synthesis of unsymmetrical bis(macrocyclic) ligands

  摘要：

  The syntheses of novel three and four carbon-bridged unsymmetrical bis(macrocyclic) ligands have been investigated. Suitable functionalization of a selectively protected 1,4,7-triazacyclononane macrocycle allows for the coupling of this well-studied ligand to either 1,4-diazacyclononane or 4,7-diaza-1-oxacyclononane.

  DOI：

  10.1016/s0040-4020(01)81895-0
• 作为产物：
  描述：

  5-氯戊醛 在 diisobutylaluminum hydride 、 potassium carbonate 作用下， 以 二氯甲烷 为溶剂， 生成 1,4-diazacyclononane
  参考文献：
  名称：

  Synthesis of medium-ring bicyclic bridgehead diamines from monocyclic diamines via α-aminoammonium ions

  摘要：

  DOI：

  10.1016/s0040-4039(00)88382-3

文献信息

• SYNTHESIS OF IMIDAZO[1,2-a]PYRAZIN-4-IUM SALTS FOR THE SYNTHESIS OF 1,4,7-TRIAZACYCLONONANE (TACN) AND N- AND/OR C-FUNCTIONALIZED DERIVATIVES THEREOF
  申请人：CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)

  公开号：US20140142298A1

  公开（公告）日：2014-05-22

  The present invention embodiments relate to a compound with formula (V′) The invention also relates in certain embodiments to the synthesis method for compound (V′) and its use for the preparation of 1,4,7-triazacyclononane (tacn) and N- and/or C-functionalized derivatives thereof, particularly compounds with formula (I) The invention also relates in certain embodiments to metallic complexes comprising a ligand with formula (I) and a metal and their use for imaging.

  本发明实施例涉及具有化学式（V′）的化合物。该发明还涉及某些实施例中化合物（V′）的合成方法，以及其用于制备1,4,7-三氮杂环壬烷（tacn）和其N-和/或C-官能化衍生物，特别是具有化学式（I）的化合物。该发明还涉及某些实施例中包括具有化学式（I）的配体和金属的金属配合物，以及它们用于成像的用途。
• BISPHOSPHONIC ACID DERIVATIVE AND COMPOUND THEREOF LABELED WITH RADIOACTIVE METAL NUCLIDE
  申请人：Dozono Hiroyuki

  公开号：US20120148492A1

  公开（公告）日：2012-06-14

  Disclosed is a radioactive bone diagnostic agent which gives a high ratio of radioactivity accumulation in bone to that in blood from an early stage after administration of the agent and allows capturing an image in a short time after administration. Also disclosed is a bisphosphonic acid derivative represented by the following chemical formula (II) or a salt thereof, wherein X represents —(CH 2 ) m CO—, Y represents —(CH 2 ) n —, R represents H, OH, or a halogen atom, m and n are independent of each other and m represents an integer of 1 to 3, and n represents an integer of 0 to 4.

  揭示了一种放射性骨诊断剂，该剂在给药后的早期阶段使骨骼中的放射性积聚与血液中的放射性积聚比值高，并且允许在给药后短时间内捕获图像。还揭示了以下化学式（II）所代表的双膦酸衍生物或其盐，其中X代表—(CH2)mCO—，Y代表—(CH2)n—，R代表H、OH或卤素原子，m和n彼此独立，m代表1到3的整数，n代表0到4的整数。
• Metalloprotein inhibitors containing nitrogen based ligands
  申请人：Cohen Seth M.

  公开号：US20120135959A1

  公开（公告）日：2012-05-31

  Provided herein metalloproteinase inhibitors containing nitrogen or mixed nitrogen/oxygen donating zinc binding groups. Also provided are pharmaceutical compositions containing the compounds and methods of treating preventing or ameliorating the diseases associated with metalloproteinase activity using the compounds and compositions.

  本文提供了含有氮或混合氮/氧供体锌结合基团的金属蛋白酶抑制剂。还提供了含有这些化合物的药物组合物，以及使用这些化合物和组合物治疗、预防或改善与金属蛋白酶活性相关的疾病的方法。
• NOVEL WATER-SOLUBLE COMPLEXING AGENTS AND CORRESPONDING LANTHANIDE COMPLEXES
  申请人：CISBIO BIOASSAYS

  公开号：US20150361116A1

  公开（公告）日：2015-12-17

  The invention relates to complexing agents of formula (I): in which A, chrom1, chrom2 and chrom3 are as defined in the description. The invention also relates to the lanthanide complexes obtained from these complexing agents.

  该发明涉及公式（I）中的络合剂：其中A、chrom1、chrom2和chrom3如描述中所定义。该发明还涉及从这些络合剂获得的镧系金属络合物。
• NOVEL COMPLEXING AGENTS AND CORRESPONDING LANTHANIDE COMPLEXES
  申请人：Lamarque Laurent

  公开号：US20140336373A1

  公开（公告）日：2014-11-13

  The present invention concerns complexing agents of formula (I) in which a, b, c, chrom 1 , chrom 2 , chrom 3 , R 3 , R 4 and R 5 are as defined in the description. The invention also concerns lanthanide complexes comprising said complexing agents, as well as a method for synthesizing said agents.

  本发明涉及具有式(I)中定义的a、b、c、chrom1、chrom2、chrom3、R3、R4和R5的络合剂。该发明还涉及包含所述络合剂的镧系金属络合物，以及一种合成所述络合剂的方法。